Baylor College of Medicine enrolling participants in COVID-19 treatment trial

Baylor College of Medicine has begun enrolling patients in a treatment trial for adult patients with a COVID-19 diagnosis. (Courtesy Adobe Stock)
Baylor College of Medicine has begun enrolling patients in a treatment trial for adult patients with a COVID-19 diagnosis. (Courtesy Adobe Stock)

Baylor College of Medicine has begun enrolling patients in a treatment trial for adult patients with a COVID-19 diagnosis. (Courtesy Adobe Stock)

Baylor College of Medicine has begun enrolling participants in a treatment trial for adult patients with a COVID-19 diagnosis hospitalized at either Baylor St. Luke’s Medical Center or Harris Health System’s Ben Taub Hospital, the hospital announced April 2.

The study will evaluate the safety and effectiveness of novel therapeutic agents, the first which is the experimental antiviral drug remdesivir.

The experimental treatment will initially be compared to a placebo, according to the news release. Researchers will interim monitor results to determine if the treatment is effective, safe, or if other treatments should be added. If a particular therapy shows positive results, then this treatment will become the standard for comparisons with new experimental treatments.

Trial participants will receive placebo or remdesivir intravenously for up to 10 days total, according to the news release. Clinicians will monitor participants regularly and assign them daily scores based on a scale of clinical outcomes that considers factors such as temperature, blood pressure and use of supplemental oxygen, along with others. Participants will be asked to provide blood samples and throat swabs, after which researchers will test the specimens for the SARS-CoV-2 virus and for the body’s response to the infection. Outcomes are scored on an eight-point scale, ranging from fully recovered to death. After 100 participants, investigators will reevaluate the scale.

On day 15, investigators will compare participant outcomes in both the remdesivir group and placebo group to determine if the drug produced clinical benefits.


Participants in the trial must have laboratory-confirmed SARS-CoV-2 infection, with evidence of pneumonia. Those individuals with confirmed infection who have mild, cold-like symptoms or no apparent symptoms will not be included.

Data from the trial, sponsored by the National Institute of Allergy and Infectious Diseases, will be monitored by an independent Data and Safety Monitoring Board to ensure patient well-being and safety as well as study integrity.
By Hunter Marrow
Hunter Marrow came to Community Impact Newspaper in January 2020. Before that, Hunter covered local news in Ontario, OR for three years, covering municipal issues, crime, and education across Malheur County and across the border into Idaho.


MOST RECENT

The COVID-19 recession, which is considered to have started both domestically and globally in late February, is unlike any other economic downturn in recent history, one expert said: It could potentially be much longer-lasting than a traditional recession. (Courtesy Pexels)
Sales tax revenue rebounds in some Houston cities following COVID-19 shutdowns

While revenue data shows both positive and negative regional trends in 2020, experts said businesses must brace for more changes as the economy fluctuates.

Lanier Middle School
Houston ISD: 17 campuses close with confirmed or presumed cases of COVID-19

The district's is reporting 90 total cases, including 10 cases among students, as of Oct. 20.

(Community Impact Newspaper staff)
Greater Houston region faces glut of industrial, commercial space and multifamily housing

While the Greater Houston area has seen a glut of office space for the last six years, Patrick Jankowski said the industrial buildup has happened more in the past year and a half.

Bellaire City Council has decided against allocating $150,000 in federal COVID-19 relief funding to set up a small-business program. (Adobe Stock Photo)
Bellaire City Council holds off on business relief with CARES Act funding

Instead, council members agreed that the $1 million should remain in the general fund.

The North Houston Highway Improvement Project proposes rerouting I-45 through the East End and Fifth Ward and expanding it through the Northside. (Nathan Colbert/Community Impact Newspaper)
Houston-Galveston Area Council seeking feedback on I-45 project plans

Regional leaders are accepting feedback on which projects to fund alongside the I-45 overhaul.

Houston police
Houston will spend $4.1 million from CARES Act to rein in rising crime rate

Violent crime is up 11% in the city of Houston and there are six hot spots throughout the city that are seeing the most violent crime numbers.

West University Elementary
DATA: How many Houston ISD students returned to in-person classes by campus

Only 10% of parents opted for in-person at Carnegie Vanguard High School, whereas 72% of West University Elementary School parents did so.

Houston ISD officials said 40% of parents are opting to continue virtual learning for the rest of 2020. (Community Impact staff)
As Houston ISD resumes in-person classes, officials tout effort to close digital gap

Some 110,000 devices have been distributed to help close the digital divide.

New Target store
Target set to open newest Inner Loop location

Target fills the space left by a former Randalls grocery store.

Voters wait in line at a Cy-Fair polling location Oct. 16. (Danica Lloyd/Community Impact Newspaper)
Day 7 of early voting brings 91,000 in-person, mail voters in Harris County

Eleven days of early voting remain before the Nov. 3 general election.